TrialLancet (London, England)2013

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.

Dominique Baeten et al.PubMed ↗Publisher ↗

No numbers read from the abstract.